Envisagenics is a biotechnology company that applies AI to the genetic sequence of patients to discover new therapies. The company focuses on RNA splicing, a cellular process occurring in every cell that “edits” RNA to produce functional proteins required for our body to work. Its proprietary cloud-based discovery platform, SpliceCoreTM, uses machine learning to prioritize new drug target candidates from patients’ RNA, our genetic blueprint.